| St. Luke's Methodist Hospital | |
|
1026 A Ave Ne Cedar Rapids IA 52402-5036 | |
| (319) 369-7211 | |
| Not Available |
| Full Name | St. Luke's Methodist Hospital |
|---|---|
| Speciality | Internal Medicine |
| Location | 1026 A Ave Ne, Cedar Rapids, Iowa |
| Authorized Official Name and Position | Milton E Aunan (VP & CFO) |
| Authorized Official Contact | 3193697094 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| St. Luke's Methodist Hospital Po Box 9306 Des Moines IA 50306-9306 Ph: (515) 471-9373 | St. Luke's Methodist Hospital 1026 A Ave Ne Cedar Rapids IA 52402-5036 Ph: (319) 369-7211 |
| NPI Number | 1073553939 |
|---|---|
| Provider Enumeration Date | 06/08/2006 |
| Last Update Date | 07/18/2011 |
| Medicare PECOS PAC ID | 6608786751 |
|---|---|
| Medicare Enrollment ID | O20040204000942 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073553939 | NPI | - | NPPES |
| C62126 | Other | IA | RR MEDICARE |
| 0098098 | Medicaid | IA |
| Provider Name | Cindy L Hanawalt |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316930779 PECOS PAC ID: 0244123321 Enrollment ID: I20040203000838 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Diane M Hoover |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073598215 PECOS PAC ID: 3476525270 Enrollment ID: I20040811001146 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Krishnarao Gorrepati |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1588624811 PECOS PAC ID: 2062405095 Enrollment ID: I20041027000116 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Dustin L Arnold |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689617144 PECOS PAC ID: 9234193038 Enrollment ID: I20041111001041 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Farid F Manshadi |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1033197165 PECOS PAC ID: 2062476724 Enrollment ID: I20041112001110 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Hisham M Wagdy |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1053396283 PECOS PAC ID: 6901856343 Enrollment ID: I20050124001082 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Keith J Kopec |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1588649875 PECOS PAC ID: 8729038161 Enrollment ID: I20050124001085 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Boothapuri Venkatesh |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1023093259 PECOS PAC ID: 0143279281 Enrollment ID: I20050314000168 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Subhi A Abu Halawa |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1417932708 PECOS PAC ID: 9133195803 Enrollment ID: I20050317000904 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Mohit K Chawla |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1861477002 PECOS PAC ID: 7315988367 Enrollment ID: I20050519000588 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Susan M Halter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144241837 PECOS PAC ID: 7416988647 Enrollment ID: I20050826000423 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Todd T Langager |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1992780183 PECOS PAC ID: 6709838956 Enrollment ID: I20050826000719 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | James Russell Bell |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1528044310 PECOS PAC ID: 5193740785 Enrollment ID: I20051012001047 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ladonna Woerdeman |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1366522948 PECOS PAC ID: 3274559497 Enrollment ID: I20051018000234 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ron Mark Oren |
|---|---|
| Provider Type | Practitioner - Advanced Heart Failure And Transplant Cardiology |
| Provider Identifiers | NPI Number: 1366422438 PECOS PAC ID: 5395761134 Enrollment ID: I20051020000556 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Julie K Shaw |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730165473 PECOS PAC ID: 3779502547 Enrollment ID: I20051122000368 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Marina V Stankovich |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578527974 PECOS PAC ID: 3779504287 Enrollment ID: I20051213000186 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Anita T Simison |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1629036546 PECOS PAC ID: 5698782662 Enrollment ID: I20060315000801 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ahmet Ersin Atay |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1093790362 PECOS PAC ID: 2264484419 Enrollment ID: I20060327000879 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Richard T Kettelkamp |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1922042894 PECOS PAC ID: 0749290674 Enrollment ID: I20060421000387 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amy J Ganske |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891891339 PECOS PAC ID: 3173529849 Enrollment ID: I20061020000210 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Roy H Lidtke |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1386641165 PECOS PAC ID: 2163456914 Enrollment ID: I20070404000635 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Garry D Weide |
|---|---|
| Provider Type | Practitioner - Thoracic Surgery |
| Provider Identifiers | NPI Number: 1760559496 PECOS PAC ID: 3476658782 Enrollment ID: I20070416000287 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Meena Veluri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326249608 PECOS PAC ID: 6608968003 Enrollment ID: I20070815000158 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | James Michael Levett |
|---|---|
| Provider Type | Practitioner - Thoracic Surgery |
| Provider Identifiers | NPI Number: 1154329092 PECOS PAC ID: 0749374643 Enrollment ID: I20070924000141 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Carla S Huber |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912193129 PECOS PAC ID: 3971690892 Enrollment ID: I20071024000555 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Holli A Lefavour |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1194741157 PECOS PAC ID: 6800859513 Enrollment ID: I20080410000655 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Matthew J Mcmahon |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1588692818 PECOS PAC ID: 6103840822 Enrollment ID: I20080624000524 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Judith K Anderson Bruner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750331039 PECOS PAC ID: 5890862932 Enrollment ID: I20080916000233 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Dana J Messenger |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1841493392 PECOS PAC ID: 0244397461 Enrollment ID: I20090316000112 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ralph Saintfort |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1184617995 PECOS PAC ID: 6002843810 Enrollment ID: I20090324000481 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Adam L Shires |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1558441386 PECOS PAC ID: 4486707213 Enrollment ID: I20090727000662 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Wassef Karrowni |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1972713691 PECOS PAC ID: 0143375857 Enrollment ID: I20090902000181 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Patti A Zessin |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1336261866 PECOS PAC ID: 8426194598 Enrollment ID: I20091002000122 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Weiwei Li |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1871791210 PECOS PAC ID: 5193861292 Enrollment ID: I20091002000398 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Karen A Nelson Rietz |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1295721835 PECOS PAC ID: 6103964994 Enrollment ID: I20091116000570 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Stanley J Mathew |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1003053653 PECOS PAC ID: 5193874584 Enrollment ID: I20091214000184 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brian Olshansky |
|---|---|
| Provider Type | Practitioner - Cardiac Electrophysiology |
| Provider Identifiers | NPI Number: 1962483347 PECOS PAC ID: 2062552110 Enrollment ID: I20100119000137 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Daniel A Trautman |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1912985680 PECOS PAC ID: 1759424971 Enrollment ID: I20100210000044 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | John P Herring |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1083694590 PECOS PAC ID: 4688577760 Enrollment ID: I20100513000401 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Julie A Thompson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710003454 PECOS PAC ID: 3870626914 Enrollment ID: I20100727000351 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Douglas J Purdy |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1376528562 PECOS PAC ID: 9032243720 Enrollment ID: I20100817000768 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Leon L Qiao |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1013992205 PECOS PAC ID: 0244364891 Enrollment ID: I20100818000034 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Sarah R Kluesner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679889661 PECOS PAC ID: 5395861868 Enrollment ID: I20100922000617 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jennifer N Blume |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407166473 PECOS PAC ID: 0244426377 Enrollment ID: I20101201000160 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Renee M Grummer-miller |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1598891269 PECOS PAC ID: 0244308641 Enrollment ID: I20101208000036 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Eric T Johnson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1144438052 PECOS PAC ID: 8628259165 Enrollment ID: I20110216001072 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Laila A Payvandi |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1922261213 PECOS PAC ID: 9436335742 Enrollment ID: I20110523000392 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ahmed M Abualfoul |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1154504504 PECOS PAC ID: 9739367343 Enrollment ID: I20110630000471 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Addie N Ketelsen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043519499 PECOS PAC ID: 7012195423 Enrollment ID: I20110706000333 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Pavan Chepyala |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1982828133 PECOS PAC ID: 5597833954 Enrollment ID: I20110803000306 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brook N Sternberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376827113 PECOS PAC ID: 7315113198 Enrollment ID: I20111228000423 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amit Pathak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225397037 PECOS PAC ID: 8729244082 Enrollment ID: I20120801000086 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Niyati Sharma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1942596986 PECOS PAC ID: 0244486736 Enrollment ID: I20120816000434 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Deepti S Kurra |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1255561023 PECOS PAC ID: 7618126574 Enrollment ID: I20121009000578 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Benjamin A Tallman |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1316291958 PECOS PAC ID: 3870743651 Enrollment ID: I20121101000640 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Melissa A Janssen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245584564 PECOS PAC ID: 1557516572 Enrollment ID: I20130223000118 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Melissa M Collier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356692131 PECOS PAC ID: 9638324502 Enrollment ID: I20130226000043 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amanda M Oconnor |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1982867628 PECOS PAC ID: 0648416131 Enrollment ID: I20130430000153 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Matthew J Kidwell |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1508092552 PECOS PAC ID: 2860639846 Enrollment ID: I20130510000419 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jessica L Deblois |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033552070 PECOS PAC ID: 6608016696 Enrollment ID: I20130716000524 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Waseemuddin Ahmed |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1497913305 PECOS PAC ID: 1759532625 Enrollment ID: I20130820000995 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Kathryn R Reed |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1487880258 PECOS PAC ID: 3870736960 Enrollment ID: I20130820001063 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Linda D Hodges |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528074671 PECOS PAC ID: 0547386740 Enrollment ID: I20130904000303 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Leslie M Greenlee |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1700105780 PECOS PAC ID: 5496989691 Enrollment ID: I20131001000285 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Erin E Brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407297351 PECOS PAC ID: 4587890165 Enrollment ID: I20131204001657 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Sachin S Nunnewar |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1114161908 PECOS PAC ID: 1850445578 Enrollment ID: I20131206000822 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Claire M Baumgartner |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1952575524 PECOS PAC ID: 5698924066 Enrollment ID: I20131217002008 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Sarah R Cole |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871927681 PECOS PAC ID: 7214165109 Enrollment ID: I20140123000800 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amanda Mary Forystek |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679866123 PECOS PAC ID: 9638319767 Enrollment ID: I20140314001940 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Eric N Boyum |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1093034266 PECOS PAC ID: 7517107956 Enrollment ID: I20140319002351 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Evan Q Ouyang |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1477848190 PECOS PAC ID: 6608016027 Enrollment ID: I20140410000211 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Georges P Hajj |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1619175114 PECOS PAC ID: 5294974721 Enrollment ID: I20140506001867 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Erin E Balk |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942615042 PECOS PAC ID: 3971721069 Enrollment ID: I20140903001078 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | William Ching |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1285831636 PECOS PAC ID: 2062584584 Enrollment ID: I20140915001725 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Kristy Ann Kapfhamer |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1518109172 PECOS PAC ID: 9537393632 Enrollment ID: I20140918002384 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Megan M Adams-rieck |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1558568469 PECOS PAC ID: 0244310746 Enrollment ID: I20141010001051 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Sharon A Collins |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1730186958 PECOS PAC ID: 6608098736 Enrollment ID: I20141105001432 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Andrea Nicole Weber |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205194370 PECOS PAC ID: 9830339969 Enrollment ID: I20150105000741 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jason Joseph Miiller |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699069138 PECOS PAC ID: 7810117702 Enrollment ID: I20150314000221 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jamsheed H Khan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578850277 PECOS PAC ID: 6002133261 Enrollment ID: I20150326001998 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Terrie Lee Vann Ward |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093706194 PECOS PAC ID: 6709875248 Enrollment ID: I20150424000863 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Michael J Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104175405 PECOS PAC ID: 3779735683 Enrollment ID: I20150504002270 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ojas Bansal |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1467766410 PECOS PAC ID: 2769702406 Enrollment ID: I20150521000349 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jay Diaz-parlet |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1417011875 PECOS PAC ID: 9032246046 Enrollment ID: I20150610000685 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ankur Vyas |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1528222320 PECOS PAC ID: 1052551082 Enrollment ID: I20150707002423 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Manuel Proenza |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1336401256 PECOS PAC ID: 9931348521 Enrollment ID: I20150717001132 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Shana Lea Coker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376860502 PECOS PAC ID: 7719106400 Enrollment ID: I20150730011236 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Wesley R Benn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174905772 PECOS PAC ID: 5496069619 Enrollment ID: I20150731016975 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Lisa Jo Mahoney |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861875635 PECOS PAC ID: 5294040614 Enrollment ID: I20150813012230 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Molly A Garber |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871979823 PECOS PAC ID: 1759697451 Enrollment ID: I20150826000272 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Oluwarotimi Adepoju |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1982950937 PECOS PAC ID: 6608182084 Enrollment ID: I20150831001795 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Katie M Maybanks |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396120036 PECOS PAC ID: 3274849146 Enrollment ID: I20150909000564 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Devin Rh Smith |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1306136197 PECOS PAC ID: 0941517437 Enrollment ID: I20150916000849 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amiee L Luedeman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881061471 PECOS PAC ID: 5294042727 Enrollment ID: I20150916002100 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Kiley S Schroeder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750753174 PECOS PAC ID: 2668782087 Enrollment ID: I20151113001410 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Aubrie A Stuckey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679944904 PECOS PAC ID: 6800196379 Enrollment ID: I20151207000233 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Naomi Bloom |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1851464846 PECOS PAC ID: 4880760982 Enrollment ID: I20151210002663 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ravneet Gill |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1013352004 PECOS PAC ID: 6800039900 Enrollment ID: I20160209000999 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ginger R Massey |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1326058074 PECOS PAC ID: 4789687187 Enrollment ID: I20160425001581 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Richard T Pardilla |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1467879619 PECOS PAC ID: 6901022847 Enrollment ID: I20160606001345 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Cyndi J Mccormick |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1356754337 PECOS PAC ID: 2365660867 Enrollment ID: I20160623001916 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Fahed Al Darazi |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1497063200 PECOS PAC ID: 9234376153 Enrollment ID: I20160708001936 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Corissa Vidal |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134570278 PECOS PAC ID: 3476846304 Enrollment ID: I20160729000378 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Michelle M Wenzel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639522899 PECOS PAC ID: 8527352038 Enrollment ID: I20160805001774 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brittni M Benda |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821333774 PECOS PAC ID: 4880988070 Enrollment ID: I20160811000133 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Nicholas R Appleby |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1396002960 PECOS PAC ID: 2769701275 Enrollment ID: I20160811000178 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Emily J Fye |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588118731 PECOS PAC ID: 8123313319 Enrollment ID: I20160826001879 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Kyle Preuninger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811443450 PECOS PAC ID: 2466749387 Enrollment ID: I20160921000389 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Timothy Daniel Park |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1841602315 PECOS PAC ID: 2062639586 Enrollment ID: I20160926001574 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Usha H Chhatlani |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669891719 PECOS PAC ID: 6103042056 Enrollment ID: I20161025000366 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Diane K Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467652206 PECOS PAC ID: 4486935129 Enrollment ID: I20170111001963 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Marie E Volbrecht |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1265485866 PECOS PAC ID: 3678573557 Enrollment ID: I20170518000131 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Bethany A Kirton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548794951 PECOS PAC ID: 6901174515 Enrollment ID: I20170622000630 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Teresa Anne Young |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1124331699 PECOS PAC ID: 9830463413 Enrollment ID: I20170920001810 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jamie M Truscott |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1013350289 PECOS PAC ID: 9537461934 Enrollment ID: I20171013001701 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Heather N Dommer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417475971 PECOS PAC ID: 9436425543 Enrollment ID: I20171017002954 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jennifer B Driscoll |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497260491 PECOS PAC ID: 6507127081 Enrollment ID: I20180223002507 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jacob N Miller |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1548613490 PECOS PAC ID: 1052605524 Enrollment ID: I20180703002150 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Katheryn L Paulsen |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1427445790 PECOS PAC ID: 2860706751 Enrollment ID: I20180911002460 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Nhan-ai T Truong |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1114313913 PECOS PAC ID: 3173823010 Enrollment ID: I20181030002052 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Mackenzie A Behof |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578031951 PECOS PAC ID: 1456694462 Enrollment ID: I20190515000092 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Tiffany Marie Ehlers |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205491552 PECOS PAC ID: 9335474642 Enrollment ID: I20190709002109 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Arpit Sothwal |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1518309681 PECOS PAC ID: 9133420888 Enrollment ID: I20190827001402 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Tyrone Galbreath |
|---|---|
| Provider Type | Practitioner - Cardiac Surgery |
| Provider Identifiers | NPI Number: 1356636245 PECOS PAC ID: 7416178199 Enrollment ID: I20190916000545 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Heather M Mactaggart |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275165482 PECOS PAC ID: 5496184145 Enrollment ID: I20200401002627 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Murtadha Abdulhussein |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1316280738 PECOS PAC ID: 0547529752 Enrollment ID: I20200612001035 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amy Leclere |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083224844 PECOS PAC ID: 9739599051 Enrollment ID: I20201027002774 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Hope E Breitbach |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568075331 PECOS PAC ID: 1052725553 Enrollment ID: I20210125000995 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Maria Swisher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568063667 PECOS PAC ID: 1153736780 Enrollment ID: I20210212001122 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jennifer Christine Hohneke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558995589 PECOS PAC ID: 6305251794 Enrollment ID: I20210217001164 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Kathryn Elizabeth Farley |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1306453121 PECOS PAC ID: 0446665517 Enrollment ID: I20210223001902 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Andreas Kyvernitakis |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1538556717 PECOS PAC ID: 3274821475 Enrollment ID: I20211008001266 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brittney Nicole Both |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164093365 PECOS PAC ID: 7911395603 Enrollment ID: I20211029000879 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Maridith Hollis |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1730612086 PECOS PAC ID: 9234484213 Enrollment ID: I20211124000974 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Bill T Chen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1023578713 PECOS PAC ID: 5698001410 Enrollment ID: I20211129000472 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Talha A Farid |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1396090353 PECOS PAC ID: 0042614190 Enrollment ID: I20211202001314 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Alvise F Bernabei |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1588679013 PECOS PAC ID: 0941218507 Enrollment ID: I20211221002056 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | A. Michael Borkon |
|---|---|
| Provider Type | Practitioner - Thoracic Surgery |
| Provider Identifiers | NPI Number: 1336190602 PECOS PAC ID: 6002707908 Enrollment ID: I20220131000141 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Tanner N Castel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417602418 PECOS PAC ID: 9537554951 Enrollment ID: I20220322002986 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amy Vincent |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598425720 PECOS PAC ID: 1951796218 Enrollment ID: I20220323001608 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Kelli Marie Udelhofen |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1962663468 PECOS PAC ID: 6800065145 Enrollment ID: I20220603000916 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | William E Curtis |
|---|---|
| Provider Type | Practitioner - Thoracic Surgery |
| Provider Identifiers | NPI Number: 1215090527 PECOS PAC ID: 0042220071 Enrollment ID: I20220606001181 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brandan K Penaluna |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497312326 PECOS PAC ID: 9133454242 Enrollment ID: I20220707001877 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Eugene Crafton |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1508874850 PECOS PAC ID: 0042388795 Enrollment ID: I20220902001116 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Jess Joymon |
|---|---|
| Provider Type | Practitioner - Thoracic Surgery |
| Provider Identifiers | NPI Number: 1598916405 PECOS PAC ID: 0042500704 Enrollment ID: I20221013001577 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Cyril E Tabe |
|---|---|
| Provider Type | Practitioner - Thoracic Surgery |
| Provider Identifiers | NPI Number: 1558457135 PECOS PAC ID: 4183624125 Enrollment ID: I20221207003118 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brooke O Olson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1992384903 PECOS PAC ID: 6204238116 Enrollment ID: I20230602000107 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Xiaoxi Yang |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578068375 PECOS PAC ID: 2860748480 Enrollment ID: I20230622002825 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Brigid Adviento |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1265924849 PECOS PAC ID: 2668729302 Enrollment ID: I20230627002159 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Carolyn Wong |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1952937880 PECOS PAC ID: 6709208275 Enrollment ID: I20230703001584 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Bailey J Zaruba |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053099051 PECOS PAC ID: 3870954738 Enrollment ID: I20230725003822 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Elissa Charlotte Zakrasek |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1720397946 PECOS PAC ID: 6507119070 Enrollment ID: I20231116001258 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Heather Harris |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1336394766 PECOS PAC ID: 6608144217 Enrollment ID: I20231128002322 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Ashfaq A. Khan |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1093754731 PECOS PAC ID: 5698763738 Enrollment ID: I20240105000987 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Nidhi Madan |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1285049197 PECOS PAC ID: 2860762101 Enrollment ID: I20240119000311 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Michele Tangeman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730951922 PECOS PAC ID: 0244683191 Enrollment ID: I20240127000400 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
| Provider Name | Amanda Jo Norton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669159117 PECOS PAC ID: 1153774542 Enrollment ID: I20240201002640 |
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
News Archive
OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.
An off-the-shelf dietary supplement available for pennies per dose demonstrated the ability to reverse cellular damage linked to specific genetic mutations in transgenic fruit flies, an experimental model of genetic mutation-induced renal cell injury that features striking similarities to humans, a Children's National Health System research team reports April 20 in Journal of the American Society of Nephrology.
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference.
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.
› Verified 3 days ago
Cedar Rapids Pediatric Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1962 1st Ave Ne, Cedar Rapids, IA 52402 Phone: 319-351-0963 | |
Cedar Rapids Pediatric Dentistry Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1962 1st Ave Ne, Cedar Rapids Pediatric Dentistry, Cedar Rapids, IA 52402 Phone: 319-364-2413 | |
Affordable Dentures & Implants - Cedar Rapids Iii, P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3135 Wiley Blvd Sw Ste 104, Cedar Rapids, IA 52404 Phone: 319-362-7037 | |
Cedar Rapids Periodontics & Dental Implants Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2727 1st Ave Se Ste 3, Cedar Rapids, IA 52402 Phone: 319-365-6150 | |
Dental Touch Associates Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5945 Council St Ne # B, Cedar Rapids, IA 52402 Phone: 319-373-5082 Fax: 319-373-7083 | |
Cedar Rapids Endodontics Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2750 1st Ave Ne, Ste 410, Cedar Rapids, IA 52402 Phone: 319-365-1456 Fax: 319-261-0118 |